Favezelimab (Anti-LAG3 / CD223)Favezelimab (Anti-LAG3 / CD223)
Move your mouse over image or click to enlarge

Favezelimab (Anti-LAG3 / CD223)

Favezelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody that targets LAG-3. It has the potential for colorectal cancer (CRC) research. MW :145.98 KD.
Cat# Size Price Qty Buy
A2994-1mg*25 1mg*25
£4,152.00
A2994-1mg*5 1mg*5
£1,384.00
A2994-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2994

Related Documents